Overview

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
This trial evaluated how effective and safe Cipro XR was in treating female patients with signs and symptoms of a lower urinary tract infections. After 3 days of treatment, patients were evaluated to determine if signs/symptoms disappeared and the infecting bacteria was eliminated.
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Treatments:
Ciprofloxacin